Ikeuchi T, Ueno M, Yogi S, Hasegawa K, Sasaki H, Hamashima T
Department of Urology, Fujigaoka Hospital, School of Medicine, Showa University.
Hinyokika Kiyo. 1991 Dec;37(12):1677-82.
We analyzed the incidence of anal disease in patients with nonbacterial prostatitis (NBP) or with prostatitis-like syndrome (PLS), and evaluated the clinical efficacy. The complicated rate of anal disease in these patients was 29.7% (31.8% for NBP and 28.1% for PLS), and the overall incidence of active anal disease was 15.4% (16.2% for NBP and 14.8% for PLS), it yielded a significantly higher complicated rate than other urological disease (p less than 0.01). The most common type of anal disease was hemorrhoids, especially piles. The clinical cure rate for anal disease in NBP patients was 71.4%, and in PLS patients was 58.2%. The high incidence of hemorrhoids (especially piles) was in these patients by clinico-statistical observation suggests that the development of anal disease may be etiologically correlated with NBP and PLS. Furthermore, we noted that Kampo treatment (Keisibukuryogan) was useful in the treatment of prostatitis complicated by anal disease, especially when combined with anti-hemorrhoidal suppositories against active anal disease in PLS patients (p less than 0.05).
我们分析了非细菌性前列腺炎（NBP）或前列腺炎样综合征（PLS）患者肛门疾病的发病率，并评估了临床疗效。这些患者肛门疾病的并发症发生率为29.7%（NBP为31.8%，PLS为28.1%），活动性肛门疾病的总体发生率为15.4%（NBP为16.2%，PLS为14.8%），其并发症发生率显著高于其他泌尿系统疾病（p<0.01）。最常见的肛门疾病类型是痔疮，尤其是内痔。NBP患者肛门疾病的临床治愈率为71.4%，PLS患者为58.2%。临床统计观察显示，这些患者中痔疮（尤其是内痔）的高发病率表明，肛门疾病的发生可能在病因上与NBP和PLS相关。此外，我们注意到，汉方治疗（柴芍六君子汤）对伴有肛门疾病的前列腺炎治疗有效，尤其是与抗痔疮栓剂联合使用时，对PLS患者的活动性肛门疾病治疗效果更佳（p<0.05）。
